Increased Levels of Serum lnterleukin-18 in Graves' Disease
Authors:
- Bunzo MatsuuraBMBunzo Matsuura
- Morikazu OnjiMOMorikazu Onji
- 1 September 2000
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 10 (9) , 815-819
Abstract
We have previously reported that serum soluble interleukin-2 receptor (sIL-2R) and IL-12 levels were significantly increased in hyperthyroid Graves' disease. In this study, we investigated serum IL-18 levels in patients with either Graves' disease or Hashimoto's thyroiditis. The serum IL-18 levels in Graves' disease were significantly increased in the hyperthyroid state and were decreased during treatment with methimazole or propylthiouracil. On the other hand, the levels in Hashimoto's thyroiditis in the hypothyroid state showed no significant differences from those in healthy subjects. When liothyronine sodium was administered orally to healthy subjects, serum IL-18 levels were not changed. Positive correlations between serum IL-18 and IL-12, IL-12 and sIL-2R, and sIL-2R and IL-18 levels were noted in Graves' disease. These results suggest that Thl cytokines might play an important regulatory role in Graves' disease.Keywords
This publication has 24 references indexed in Scilit:
- The involvement of IL-12 in murine experimentally induced autoimmune thyroid diseaseEuropean Journal of Immunology, 1999
- Increased Serum Concentration of Interleukin-5 in Patients with Graves' Disease and Hashimoto's ThyroiditisThyroid®, 1998
- Single‐cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' diseaseEuropean Journal of Immunology, 1997
- Thyrotropin-Receptor and Thyroid Peroxidase-Specific T Cell Clones and Their Cytokine Profile in Autoimmune Thyroid DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1997
- Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast FormationJournal of Experimental Medicine, 1997
- Detection of IL-12, IL-13, and IL-15 Messenger Ribonucleic Acid in the Thyroid of Patients with Autoimmune Thyroid DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1997
- Different Cytokine mRNA Profiles in Graves' Disease, Hashimoto's Thyroiditis, and Nonautoimmune Thyroid Disorders Determined by Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)Thyroid®, 1996
- Semi-quantitative analysis of interleukin-1α, interleukin-6 and interleukin-8 mRNA expression by human thyrocytesJournal of Molecular Endocrinology, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cellsClinical Immunology and Immunopathology, 1992